ReviR Therapeutics: Funding, Investors & Team (Sep 2026)
ReviR Therapeutics is a platform rooted in genomics that creates innovative medications aimed at human RNAs. Their RNA-based treatments address various conditions like cancer, rare genetic diseases, and infections. Additionally, they utilize AI technology and computational methods to identify RNA-targeted therapies.
ReviR Therapeutics has raised $30.0M across 2 funding rounds on record, the most recent an undisclosed round announced in Apr 2026.
ReviR Therapeutics Company Profile and Key Stats
Latest funding round on record: Apr 2026.
ReviR Therapeutics Funding Rounds
1 of 2 rounds was announced without a disclosed amount and is excluded from the total.
ReviR Therapeutics raised $30.0M in a Series A announced in Jul 2024.
1.8 years later, an undisclosed round was announced in Apr 2026 with no disclosed amount.
ReviR Therapeutics Founders and Leadership Team
Contact details for the ReviR Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →ReviR Therapeutics Funding Compared to Other Biotechnology Startups
Funded Startups Like ReviR Therapeutics in Biotechnology and Brisbane
Companies Similar to ReviR Therapeutics
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Datavant is a developer of a healthcare data platform dedicated to assisting in protecting, matching, and…
Shennon Biotechnologies conducts a thorough examination and control of an enormous quantity of cells,…
SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory…
DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer…
Solstice Oncology is a clinical stage immuno-oncology company
Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad…
BrainChild Bio is a biotechnology company in the clinical stage that specializes in pediatric brain tumors.…
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
ReviR Therapeutics Funding FAQs
What does ReviR Therapeutics do?
ReviR Therapeutics is a platform rooted in genomics that creates innovative medications aimed at human RNAs. Their RNA-based treatments address various conditions like cancer, rare genetic diseases, and infections. Additionally, they utilize AI technology and computational methods to identify RNA-targeted therapies.
How much funding has ReviR Therapeutics raised?
ReviR Therapeutics has raised $30.0M across 2 rounds on record.
When did ReviR Therapeutics last raise funding?
ReviR Therapeutics' most recent funding round on record was announced in Apr 2026. The amount was not disclosed.
Who founded ReviR Therapeutics?
FundedIQ lists Peng Yue (Founder) at ReviR Therapeutics.
Where is ReviR Therapeutics headquartered?
ReviR Therapeutics is based in Brisbane, California, United States.
How many employees does ReviR Therapeutics have?
ReviR Therapeutics is in the 11-50 employee band.
About FundedIQ's ReviR Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for ReviR Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.